PSNC Briefing 004/21: Serious Shortage Protocol (SSP): SSP010 – Levothyroxine 12.5mcg tablets
Published on: 19th February 2021 | Updated on: 9th June 2022
In response to significant ongoing disruption to the supply of levothyroxine 12.5mcg tablets, a Serious Shortage Protocol (SSP) have been issued by the Department of Health and Social Care (DHSC) and these can be accessed on the NHS Business Services Authority (NHSBSA) website. This briefing provides information on these SSPs and is intended as a short guide for contractors to read in conjunction with PSNC Briefing 023/19: Serious Shortage Protocols (SSPs) – A guide for community pharmacy teams.
If you have any queries on this PSNC Briefing or you require more information, please contact the Dispensing & Supply Team.
To browse other PSNC briefings on dispensing and supply click here.
For more information on this topic please email firstname.lastname@example.org